About Piramal Group
Piramal Group is a company based in Mumbai (India) founded in 1984. The company has 16,400 employees as of March 31, 2024. Piramal Group has completed 8 acquisitions, including Ash Stevens, Biosyntech and Coldstream Labs. Piramal Group offers products and services including Housing Finance, Pharma Solutions, and Realty Development. Piramal Group operates in a competitive market with competitors including Abzena, Patheon, Syngene, Panacea Biotec and Maravai Life Sciences, among others.
- Headquarter Mumbai, India
- Employees 16400 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Piramal Enterprises Ltd.
-
Annual Revenue
$788.08 M (USD)18.19as on Mar 31, 2024
-
Net Profit
$56.66 M (USD)128.8as on Mar 31, 2024
-
EBITDA
$375.12 M (USD)28.71as on Mar 31, 2024
-
Latest Funding Round
-
Investors
The Carlyle Group
& 2 more
-
Employee Count
16400
as on Mar 31, 2024
-
Investments & Acquisitions
Ash Stevens
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Piramal Group
Piramal Group is a publicly listed company on the NSE with ticker symbol PPLPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Piramal Group
Piramal Group offers a comprehensive portfolio of products and services, including Housing Finance, Pharma Solutions, and Realty Development.
Provides loans and financing for housing needs
Offers manufacturing and distribution of pharmaceutical products
Focuses on property development and community projects
People of Piramal Group
Unlock access to complete
Unlock access to complete
Funding Insights of Piramal Group
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Post-IPO - Piramal Group | Valuation |
investors |
|
| Dec, 2019 | Amount | Post-IPO - Piramal Group | Valuation |
investors |
|
| Oct, 2019 | Amount | Post-IPO - Piramal Group | Valuation |
investors |
Investors in Piramal Group
Piramal Group has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group, Caisse de depot et placement du Quebec and Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment strategies are provided across diverse asset classes and markets.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Piramal Group
Piramal Group has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Ash Stevens, Biosyntech and Coldstream Labs.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Formulation development and contract manufacturing services are provided in pharmaceuticals.
|
2007 | ||||
|
Care coordination solutions for healthcare organizations
|
2007 | ||||
|
A single-use device used to obtain biopsies of bone
|
2005 |
Financial Statements - Piramal Group
Piramal Group Comparisons
Competitors of Piramal Group
Piramal Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Panacea Biotec and Maravai Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Developer of biosimilars, vaccines and natural products
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
Frequently Asked Questions about Piramal Group
Piramal Group was founded in 1984 and raised its 1st funding round 27 years after it was founded.
Piramal Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Peter De Young is the current CEO of Piramal Group.
As of Mar 31, 2024, the latest employee count at Piramal Group is 16,400.
Annual revenue of Piramal Group is $788.08M as on Mar 31, 2024.
Founded in 1984 and headquartered in Mumbai, India, Piramal Group maintains a multinational presence across pharmaceuticals, healthcare services, life sciences, specialty glass packaging, and real estate sectors. Subsidiaries such as Piramal Healthcare, Piramal Capital, Decision Resources Group, Piramal Glass, Piramal Realty, and Piramal Foundation are included. Contract development and manufacturing solutions for first-in-class drugs, generics, and antibody drug conjugates are provided to pharma and biotech firms.
Piramal Group's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Piramal Group offers Housing Finance, Pharma Solutions, and Realty Development.
Yes, Piramal Group is publicly traded on NSE under the ticker symbol PPLPHARMA.
Piramal Group has made 8 acquisitions, including Ash Stevens, Biosyntech, and Coldstream Labs.
Piramal Group has 3 investors. Key investors include The Carlyle Group, Caisse de depot et placement du Quebec, and Department of Biotechnology.
The ticker symbol of Piramal Group is PPLPHARMA on NSE.